Anti‐Inflammatory Activity of Novel Dehydrozingerone‐6 (DHZ‐6) Through Modulation of iNOS, COX‐2, and NF‐κB/p65 in LPS‐Stimulated Macrophages and In Vivo Acute Lung Injury Murine Model
Journal of Applied Toxicology · 2026
DOI: 10.1002/jat.4943 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Applied Toxicology, 2026. Verfasst von Narendra Chauhan und 5 weiteren Autor:innen. Beteiligte Einrichtung: CSIR- Indian Institute of Integrative Medicine, Jammu, India. Hauptthemen laut MEDLINE: Acute Lung Injury, Nitric Oxide Synthase Type II, Anti-Inflammatory Agents, Cyclooxygenase 2. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 36 Literaturangaben.
Abstract (Originalsprache)
Acute lung injury (ALI) poses a significant threat in respiratory diseases and can lead to organ failure in chronic conditions. In this study, we evaluated the preventive effects of Dehydrozingerone‐6 against Lipopolysaccharide (LPS)‐induced inflammation in macrophages using RAW 264.7 and in a mouse model of ALI. During preliminary screening, Dehydrozingerone‐6 demonstrated significant inhibition of cytokines and maintained 97% cell viability at 10 μM. Further in vitro studies showed that Dehydrozingerone‐6 effectively suppressed LPS‐induced production of nitric oxide, interleukin‐6 (IL‐6), tumor necrosis factor‐alpha (TNF‐α), interferon‐gamma (IFN‐γ), interleukin‐1 beta (IL‐1β), and reactive oxygen species (ROS) at a concentration of 10 μM. Immunocytochemistry and Western blot analyses revealed reduced expression levels of inducible nitric oxide synthase (iNOS), cyclooxygenase‐2 (COX‐2), Nuclear Factor kappa B (NF‐κB/p65), and phosphorylated IκBα (p‐IκBα). In vivo LPS‐induced lung injury model revealed that Dehydrozingerone‐6 protected lung tissue from degradation and significantly inhibited IL‐6 and TNF‐α production at a dose of 50 mg/kg. Furthermore, Dehydrozingerone‐6 significantly reduced carrageenan‐induced paw edema and leukocyte migration. Dehydrozingerone‐6 also markedly reduced vascular permeability in an acetic acid‐induced model. Toxicological studies conducted at doses up to 2000 mg/kg body weight showed no notable alterations in hematological parameters or histopathology of the liver and kidney, suggesting a favorable safety profile. Overall, Dehydrozingerone‐6 exhibited strong anti‐inflammatory activity in vitro as well as in vivo studies by downregulating the generation of pro‐inflammatory mediators and oxidative stress through attenuation of iNOS, COX‐2, and NF‐κB/p65.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- CSIR- Indian Institute of Integrative Medicine, Jammu, India.
- Mutagenicity Laboratory, Pharmacology Division, CSIR- Indian Institute of Integrative Medicine, Jammu, India.
- Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, India.
- Natural Product Chemistry Division, CSIR-Indian Institute of Integrative Medicine, Jammu, India.
- SoPPHI, Faculty of Pharmacy, DIT university Dehradun, Uttarakhand, India.
ORCID-Profile: Irfan Qasam, Govind Yadav
Zitieren
APA
Chauhan, N., Qasam, I., Purohit, A., Nawaz, S., Kumar, C., & Yadav, G. (2026). Anti‐Inflammatory Activity of Novel Dehydrozingerone‐6 (DHZ‐6) Through Modulation of iNOS, COX‐2, and NF‐κB/p65 in LPS‐Stimulated Macrophages and In Vivo Acute Lung Injury Murine Model. Journal of Applied Toxicology. https://doi.org/10.1002/jat.4943
Vancouver
Chauhan N, Qasam I, Purohit A, Nawaz S, Kumar C, Yadav G. Anti‐Inflammatory Activity of Novel Dehydrozingerone‐6 (DHZ‐6) Through Modulation of iNOS, COX‐2, and NF‐κB/p65 in LPS‐Stimulated Macrophages and In Vivo Acute Lung Injury Murine Model. Journal of Applied Toxicology. 2026. doi:10.1002/jat.4943
BibTeX
@article{Chauhan2026,
author = {Chauhan, Narendra and Qasam, Irfan and Purohit, Avani and Nawaz, Shah and Kumar, Chetan and Yadav, Govind},
title = {Anti‐Inflammatory Activity of Novel Dehydrozingerone‐6 (DHZ‐6) Through Modulation of iNOS, COX‐2, and NF‐κB/p65 in LPS‐Stimulated Macrophages and In Vivo Acute Lung Injury Murine Model},
journal = {Journal of Applied Toxicology},
year = {2026},
doi = {10.1002/jat.4943}
}
EUVIMED